Capstone Capital Management Ltd

Position in BMY — Bristol Myers Squibb Co

CIK 2069260 HONG KONG, K3

Position in BMY

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$812,960

+$365,363 QoQ

Shares Held

14,109

+91.2% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.43%

of 13F equity value

Holder Rank

#1,279

of 2,506 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Capstone Capital Management Ltd holds $1,971,934 across 3 Drug Manufacturers - General names. BMY ranks #1 (41.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BMY	Bristol Myers Squibb Co This page	14,109	$812,960
2	GILD	Gilead Sciences, Inc.	6,345	$801,627
3	PFE	Pfizer Inc	14,840	$357,347

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$812,960	14,109	+91.2%	Shares	Sole	2026-07-20
2026-03-31	$447,597	7,380	—	Shares	Sole	2026-04-30
No filing history on record for this holder in this stock.